You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 2, 2024

QVAR 40 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Qvar 40 patents expire, and when can generic versions of Qvar 40 launch?

Qvar 40 is a drug marketed by Teva Branded Pharm and is included in one NDA. There are eight patents protecting this drug.

This drug has one hundred and ninety-two patent family members in twenty-four countries.

The generic ingredient in QVAR 40 is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

DrugPatentWatch® Generic Entry Outlook for Qvar 40

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be May 18, 2031. This may change due to patent challenges or generic licensing.

There have been four patent litigation cases involving the patents protecting this drug, indicating strong interest in generic launch. Recent data indicate that 63% of patent challenges are decided in favor of the generic patent challenger and that 54% of successful patent challengers promptly launch generic drugs.

There is one tentative approval for the generic drug (beclomethasone dipropionate), which indicates the potential for near-term generic launch.

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

Summary for QVAR 40
International Patents:192
US Patents:8
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 65
Patent Applications: 5,329
Formulation / Manufacturing:see details
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for QVAR 40
DailyMed Link:QVAR 40 at DailyMed
Drug patent expirations by year for QVAR 40
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for QVAR 40
Generic Entry Date for QVAR 40*:
⤷  Sign Up
Constraining patent/regulatory exclusivity:
⤷  Sign Up
NDA:
020911
Dosage:
AEROSOL, METERED;INHALATION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for QVAR 40

QVAR 40 is protected by eight US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of QVAR 40 is ⤷  Sign Up.

This potential generic entry date is based on patent ⤷  Sign Up.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting QVAR 40

Dose counter for inhaler having a bore and shaft arrangement
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler and method for counting doses
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counters for inhalers, inhalers and methods of assembly thereof
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Dose counter for inhaler having an anti-reverse rotation actuator
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Sign Up

Expired US Patents for QVAR 40

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or Sign Up

International Patents for QVAR 40

When does loss-of-exclusivity occur for QVAR 40?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 11254958
Estimated Expiration: ⤷  Sign Up

Brazil

Patent: 2012029106
Estimated Expiration: ⤷  Sign Up

Canada

Patent: 99625
Estimated Expiration: ⤷  Sign Up

Patent: 87315
Estimated Expiration: ⤷  Sign Up

Patent: 36362
Estimated Expiration: ⤷  Sign Up

Patent: 19694
Estimated Expiration: ⤷  Sign Up

Patent: 11537
Estimated Expiration: ⤷  Sign Up

China

Patent: 2892448
Estimated Expiration: ⤷  Sign Up

Patent: 5597204
Estimated Expiration: ⤷  Sign Up

Patent: 5597205
Estimated Expiration: ⤷  Sign Up

Patent: 5597206
Estimated Expiration: ⤷  Sign Up

Patent: 5903107
Estimated Expiration: ⤷  Sign Up

Patent: 5903108
Estimated Expiration: ⤷  Sign Up

Patent: 5903109
Estimated Expiration: ⤷  Sign Up

Patent: 5903110
Estimated Expiration: ⤷  Sign Up

Patent: 5903111
Estimated Expiration: ⤷  Sign Up

Patent: 5903112
Estimated Expiration: ⤷  Sign Up

Patent: 5903113
Estimated Expiration: ⤷  Sign Up

Patent: 6063964
Estimated Expiration: ⤷  Sign Up

Croatia

Patent: 0150102
Estimated Expiration: ⤷  Sign Up

Patent: 0150103
Estimated Expiration: ⤷  Sign Up

Cyprus

Patent: 16092
Estimated Expiration: ⤷  Sign Up

Patent: 16148
Estimated Expiration: ⤷  Sign Up

Patent: 16358
Estimated Expiration: ⤷  Sign Up

Denmark

Patent: 36414
Estimated Expiration: ⤷  Sign Up

Patent: 02644
Estimated Expiration: ⤷  Sign Up

Patent: 14462
Estimated Expiration: ⤷  Sign Up

Patent: 14464
Estimated Expiration: ⤷  Sign Up

Patent: 14465
Estimated Expiration: ⤷  Sign Up

Patent: 14466
Estimated Expiration: ⤷  Sign Up

Patent: 14467
Estimated Expiration: ⤷  Sign Up

Patent: 14468
Estimated Expiration: ⤷  Sign Up

Patent: 87522
Estimated Expiration: ⤷  Sign Up

Eurasian Patent Organization

Patent: 3985
Estimated Expiration: ⤷  Sign Up

Patent: 4597
Estimated Expiration: ⤷  Sign Up

Patent: 4598
Estimated Expiration: ⤷  Sign Up

Patent: 4635
Estimated Expiration: ⤷  Sign Up

Patent: 6217
Estimated Expiration: ⤷  Sign Up

Patent: 6245
Estimated Expiration: ⤷  Sign Up

Patent: 6306
Estimated Expiration: ⤷  Sign Up

Patent: 6600
Estimated Expiration: ⤷  Sign Up

Patent: 7886
Estimated Expiration: ⤷  Sign Up

Patent: 2332
Estimated Expiration: ⤷  Sign Up

Patent: 1291267
Estimated Expiration: ⤷  Sign Up

Patent: 1300230
Estimated Expiration: ⤷  Sign Up

Patent: 1300231
Estimated Expiration: ⤷  Sign Up

Patent: 1300232
Estimated Expiration: ⤷  Sign Up

Patent: 1300233
Estimated Expiration: ⤷  Sign Up

Patent: 1300234
Estimated Expiration: ⤷  Sign Up

Patent: 1300235
Estimated Expiration: ⤷  Sign Up

Patent: 1300236
Estimated Expiration: ⤷  Sign Up

Patent: 1300237
Estimated Expiration: ⤷  Sign Up

Patent: 1690640
Estimated Expiration: ⤷  Sign Up

Patent: 1690641
Estimated Expiration: ⤷  Sign Up

Patent: 1690642
Estimated Expiration: ⤷  Sign Up

European Patent Office

Patent: 36414
Estimated Expiration: ⤷  Sign Up

Patent: 02644
Estimated Expiration: ⤷  Sign Up

Patent: 14462
Estimated Expiration: ⤷  Sign Up

Patent: 14463
Estimated Expiration: ⤷  Sign Up

Patent: 14464
Estimated Expiration: ⤷  Sign Up

Patent: 14465
Estimated Expiration: ⤷  Sign Up

Patent: 14466
Estimated Expiration: ⤷  Sign Up

Patent: 14467
Estimated Expiration: ⤷  Sign Up

Patent: 14468
Estimated Expiration: ⤷  Sign Up

Patent: 87521
Estimated Expiration: ⤷  Sign Up

Patent: 87522
Estimated Expiration: ⤷  Sign Up

Patent: 87523
Estimated Expiration: ⤷  Sign Up

Hong Kong

Patent: 69049
Estimated Expiration: ⤷  Sign Up

Patent: 19066
Estimated Expiration: ⤷  Sign Up

Patent: 19067
Estimated Expiration: ⤷  Sign Up

Patent: 19069
Estimated Expiration: ⤷  Sign Up

Patent: 21919
Estimated Expiration: ⤷  Sign Up

Patent: 21920
Estimated Expiration: ⤷  Sign Up

Patent: 22138
Estimated Expiration: ⤷  Sign Up

Patent: 22811
Estimated Expiration: ⤷  Sign Up

Patent: 22812
Estimated Expiration: ⤷  Sign Up

Patent: 22813
Estimated Expiration: ⤷  Sign Up

Patent: 23309
Estimated Expiration: ⤷  Sign Up

Patent: 23310
Estimated Expiration: ⤷  Sign Up

Patent: 23311
Estimated Expiration: ⤷  Sign Up

Patent: 23312
Estimated Expiration: ⤷  Sign Up

Hungary

Patent: 26784
Estimated Expiration: ⤷  Sign Up

Patent: 26789
Estimated Expiration: ⤷  Sign Up

Patent: 26806
Estimated Expiration: ⤷  Sign Up

Patent: 26808
Estimated Expiration: ⤷  Sign Up

Patent: 29937
Estimated Expiration: ⤷  Sign Up

Patent: 42291
Estimated Expiration: ⤷  Sign Up

Israel

Patent: 3116
Estimated Expiration: ⤷  Sign Up

Patent: 3117
Estimated Expiration: ⤷  Sign Up

Patent: 3118
Estimated Expiration: ⤷  Sign Up

Patent: 7394
Estimated Expiration: ⤷  Sign Up

Patent: 7395
Estimated Expiration: ⤷  Sign Up

Patent: 7396
Estimated Expiration: ⤷  Sign Up

Patent: 7397
Estimated Expiration: ⤷  Sign Up

Patent: 7398
Estimated Expiration: ⤷  Sign Up

Patent: 7399
Estimated Expiration: ⤷  Sign Up

Patent: 7400
Estimated Expiration: ⤷  Sign Up

Patent: 7401
Estimated Expiration: ⤷  Sign Up

Patent: 7402
Estimated Expiration: ⤷  Sign Up

Patent: 3904
Estimated Expiration: ⤷  Sign Up

Japan

Patent: 97964
Estimated Expiration: ⤷  Sign Up

Patent: 06354
Estimated Expiration: ⤷  Sign Up

Patent: 06355
Estimated Expiration: ⤷  Sign Up

Patent: 20005
Estimated Expiration: ⤷  Sign Up

Patent: 20006
Estimated Expiration: ⤷  Sign Up

Patent: 20007
Estimated Expiration: ⤷  Sign Up

Patent: 96487
Estimated Expiration: ⤷  Sign Up

Patent: 00932
Estimated Expiration: ⤷  Sign Up

Patent: 33607
Estimated Expiration: ⤷  Sign Up

Patent: 27608
Estimated Expiration: ⤷  Sign Up

Patent: 73242
Estimated Expiration: ⤷  Sign Up

Patent: 01904
Estimated Expiration: ⤷  Sign Up

Patent: 64820
Estimated Expiration: ⤷  Sign Up

Patent: 13526353
Estimated Expiration: ⤷  Sign Up

Patent: 14111199
Estimated Expiration: ⤷  Sign Up

Patent: 14128707
Estimated Expiration: ⤷  Sign Up

Patent: 14128708
Estimated Expiration: ⤷  Sign Up

Patent: 14128709
Estimated Expiration: ⤷  Sign Up

Patent: 14140757
Estimated Expiration: ⤷  Sign Up

Patent: 14140758
Estimated Expiration: ⤷  Sign Up

Patent: 14144352
Estimated Expiration: ⤷  Sign Up

Patent: 14144353
Estimated Expiration: ⤷  Sign Up

Patent: 15231584
Estimated Expiration: ⤷  Sign Up

Patent: 15231585
Estimated Expiration: ⤷  Sign Up

Patent: 16025944
Estimated Expiration: ⤷  Sign Up

Patent: 16041380
Estimated Expiration: ⤷  Sign Up

Patent: 17205580
Estimated Expiration: ⤷  Sign Up

Mexico

Patent: 9742
Estimated Expiration: ⤷  Sign Up

Patent: 12012956
Estimated Expiration: ⤷  Sign Up

New Zealand

Patent: 3466
Estimated Expiration: ⤷  Sign Up

Poland

Patent: 36414
Estimated Expiration: ⤷  Sign Up

Patent: 02644
Estimated Expiration: ⤷  Sign Up

Patent: 14462
Estimated Expiration: ⤷  Sign Up

Patent: 14464
Estimated Expiration: ⤷  Sign Up

Patent: 14465
Estimated Expiration: ⤷  Sign Up

Patent: 14466
Estimated Expiration: ⤷  Sign Up

Patent: 14467
Estimated Expiration: ⤷  Sign Up

Patent: 14468
Estimated Expiration: ⤷  Sign Up

Patent: 87522
Estimated Expiration: ⤷  Sign Up

Portugal

Patent: 36414
Estimated Expiration: ⤷  Sign Up

Patent: 02644
Estimated Expiration: ⤷  Sign Up

Patent: 14467
Estimated Expiration: ⤷  Sign Up

San Marino

Patent: 01500025
Estimated Expiration: ⤷  Sign Up

Patent: 01500026
Estimated Expiration: ⤷  Sign Up

Serbia

Patent: 871
Estimated Expiration: ⤷  Sign Up

Patent: 885
Estimated Expiration: ⤷  Sign Up

Slovenia

Patent: 36414
Estimated Expiration: ⤷  Sign Up

Patent: 02644
Estimated Expiration: ⤷  Sign Up

Patent: 14467
Estimated Expiration: ⤷  Sign Up

South Africa

Patent: 1307989
Estimated Expiration: ⤷  Sign Up

Patent: 1307990
Estimated Expiration: ⤷  Sign Up

Patent: 1307991
Estimated Expiration: ⤷  Sign Up

Patent: 1307992
Estimated Expiration: ⤷  Sign Up

Patent: 1307993
Estimated Expiration: ⤷  Sign Up

Patent: 1307994
Estimated Expiration: ⤷  Sign Up

Patent: 1307995
Estimated Expiration: ⤷  Sign Up

Patent: 1307996
Estimated Expiration: ⤷  Sign Up

Patent: 1509290
Estimated Expiration: ⤷  Sign Up

South Korea

Patent: 1471739
Estimated Expiration: ⤷  Sign Up

Patent: 1559643
Estimated Expiration: ⤷  Sign Up

Patent: 1618421
Estimated Expiration: ⤷  Sign Up

Patent: 1618931
Estimated Expiration: ⤷  Sign Up

Patent: 1618932
Estimated Expiration: ⤷  Sign Up

Patent: 1618933
Estimated Expiration: ⤷  Sign Up

Patent: 1618934
Estimated Expiration: ⤷  Sign Up

Patent: 1618935
Estimated Expiration: ⤷  Sign Up

Patent: 1618936
Estimated Expiration: ⤷  Sign Up

Patent: 1618937
Estimated Expiration: ⤷  Sign Up

Patent: 1628934
Estimated Expiration: ⤷  Sign Up

Patent: 1718674
Estimated Expiration: ⤷  Sign Up

Patent: 130020903
Estimated Expiration: ⤷  Sign Up

Patent: 130101169
Estimated Expiration: ⤷  Sign Up

Patent: 130101170
Estimated Expiration: ⤷  Sign Up

Patent: 130101171
Estimated Expiration: ⤷  Sign Up

Patent: 130103820
Estimated Expiration: ⤷  Sign Up

Patent: 130103823
Estimated Expiration: ⤷  Sign Up

Patent: 130103824
Estimated Expiration: ⤷  Sign Up

Patent: 130103825
Estimated Expiration: ⤷  Sign Up

Patent: 130103826
Estimated Expiration: ⤷  Sign Up

Patent: 130103827
Estimated Expiration: ⤷  Sign Up

Patent: 130103828
Estimated Expiration: ⤷  Sign Up

Patent: 160066563
Estimated Expiration: ⤷  Sign Up

Spain

Patent: 29229
Estimated Expiration: ⤷  Sign Up

Patent: 29358
Estimated Expiration: ⤷  Sign Up

Patent: 34668
Estimated Expiration: ⤷  Sign Up

Patent: 44277
Estimated Expiration: ⤷  Sign Up

Patent: 44278
Estimated Expiration: ⤷  Sign Up

Patent: 44437
Estimated Expiration: ⤷  Sign Up

Patent: 44501
Estimated Expiration: ⤷  Sign Up

Patent: 07956
Estimated Expiration: ⤷  Sign Up

Patent: 07498
Estimated Expiration: ⤷  Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering QVAR 40 around the world.

Country Patent Number Title Estimated Expiration
Japan 2016041380 吸入器のための用量カウンタ、吸入器及びそのシャフト (DOSE COUNTERS FOR INHALERS, INHALERS AND SHAFTS THEREOF) ⤷  Sign Up
Mexico 9203481 FORMULACIONES. ⤷  Sign Up
Cyprus 1116092 ⤷  Sign Up
Japan H10182467 AEROSOL PREPARATION CONTAINING BECLOMETHAZONE 17, 21 DIPROPIONATE ⤷  Sign Up
Denmark 2514462 ⤷  Sign Up
Denmark 2987522 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group